Where is the live CopyMark page for USPTO serial 78330097?

The live record is at https://getcopymark.com/trademark/78330097. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns PHARMAMONDE?

According to the public USPTO record for serial number 78330097, the listed owner(s) include: PHARMAMONDE, INC..

What is USPTO serial number 78330097?

Serial number 78330097 is the USPTO application identifier for the mark PHARMAMONDE. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover PHARMAMONDE?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: PHARMAMONDE Serial# 78330097 | status 603; last event MAB3 | Trademark Info & Attorney Guidance

Q: What is the current status of PHARMAMONDE?

PHARMAMONDE (78330097) currently shows USPTO status code 603 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHARMAMONDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

PHARMAMONDE, INC.
St. Louis, MO
Other trademarks owned by PHARMAMONDE, INC.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James B. Surber

JAMES B SURBER BRYAN CAVE LLP1 METROPOLITAN SQ STE 3600ST LOUIS, MO 63102-2769UNITED STATES

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations, comprising small molecules, organic compounds, peptides, polypeptides, antibodies, and nucleic acids, for the treatment and prevention of AIDS, HIV infectivity, cancer, and viral related diseases	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Mar 6, 2006	MAB3	ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL	—
Mar 3, 2006	ABN3	ABANDONMENT - AFTER EX PARTE APPEAL	—
Mar 3, 2006	EXPT	EXPARTE APPEAL TERMINATED	—
Nov 2, 2005	RECD	ACTION DENYING REQ FOR RECON MAILED	—
Nov 2, 2005	CNCF	ACTION CONTINUING FINAL - COMPLETED	—
Jul 25, 2005	EXPI	EX PARTE APPEAL-INSTITUTED	—
Jul 25, 2005	JURT	JURISDICTION RESTORED TO EXAMINING ATTORNEY	—
Jul 22, 2005	EXAF	EXPARTE APPEAL RECEIVED AT TTAB	—
Jan 13, 2005	CNFR	FINAL REFUSAL MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 12, 2005	CNFR	FINAL REFUSAL WRITTEN	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 6, 2005	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Dec 22, 2004	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Dec 22, 2004	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 22, 2004	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2004	DOCK	ASSIGNED TO EXAMINER	—
Dec 11, 2003	NWAP	NEW APPLICATION ENTERED	—

PHARMAMONDE